Biotech Co. NanoString Gets OK On Ch. 11 Wind Down Plan
By Clara Geoghegan · June 18, 2024, 6:40 PM EDT
NanoString Technologies Inc., a Seattle-based maker of gene analysis technology, can use proceeds from the $393 million sale of its business to repay nearly all creditors in full after a Delaware...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login